- Home
- PFBC vs RVNC Comparison
PFBC vs RVNC Comparison
Compare PFBC & RVNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PFBC
- RVNC
- Stock Information
- Founded
- PFBC 1991
- RVNC 1999
- Country
- PFBC United States
- RVNC United States
- Employees
- PFBC N/A
- RVNC N/A
- Industry
- PFBC Major Banks
- RVNC Biotechnology: Pharmaceutical Preparations
- Sector
- PFBC Finance
- RVNC Health Care
- Exchange
- PFBC Nasdaq
- RVNC Nasdaq
- Market Cap
- PFBC 1.2B
- RVNC 320.5M
- IPO Year
- PFBC 1998
- RVNC 2014
- Fundamental
- Price
- PFBC $85.96
- RVNC $3.09
- Analyst Decision
- PFBC Buy
- RVNC Hold
- Analyst Count
- PFBC 2
- RVNC 9
- Target Price
- PFBC $99.50
- RVNC $8.45
- AVG Volume (30 Days)
- PFBC 84.1K
- RVNC 3.6M
- Earning Date
- PFBC 01-22-2025
- RVNC 11-07-2024
- Dividend Yield
- PFBC 3.26%
- RVNC N/A
- EPS Growth
- PFBC N/A
- RVNC N/A
- EPS
- PFBC 9.99
- RVNC N/A
- Revenue
- PFBC $260,387,999.00
- RVNC $256,945,000.00
- Revenue This Year
- PFBC N/A
- RVNC $11.28
- Revenue Next Year
- PFBC N/A
- RVNC $27.21
- P/E Ratio
- PFBC $8.60
- RVNC N/A
- Revenue Growth
- PFBC N/A
- RVNC 25.82
- 52 Week Low
- PFBC $66.88
- RVNC $2.30
- 52 Week High
- PFBC $99.78
- RVNC $9.75
- Technical
- Relative Strength Index (RSI)
- PFBC 33.01
- RVNC 33.47
- Support Level
- PFBC $90.71
- RVNC $3.06
- Resistance Level
- PFBC $93.26
- RVNC $3.09
- Average True Range (ATR)
- PFBC 2.38
- RVNC 0.11
- MACD
- PFBC -1.28
- RVNC 0.02
- Stochastic Oscillator
- PFBC 12.51
- RVNC 6.90
About PFBC Preferred Bank
Preferred Bank is a commercial bank located in California. Its products and services are divided into Personal Banking, Business Banking, and Commercial Banking which includes Checking accounts, Savings accounts, CDs, Loans and Credit, Electronic banking and Treasury Management. It provides personalized deposit services, real estate finance, commercial loans, and trade finance credit facilities to small and mid-sized businesses and their owners, entrepreneurs, real estate developers and investors, professionals and high-net-worth individuals. The bank generates a majority of its revenue from Southern and Northern California and Flushing.
About RVNC Revance Therapeutics Inc.
Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched a prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD platform. Its main products include DaxibotulinumtoxinA for Injection and DaxibotulinumtoxinA for Injection Aesthetics. The operating business segments are the Product and the Service Segment. The Products segment generates maximum revenue and is engaged in the research and development of aesthetic and therapeutic products.